Search the Newsreel

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Teladoc Health, Inc. (TDOC) and Encourages Investors to Learn More About the Investigation

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for purchasers of Teladoc Health securities, especially after …

Teladoc Health (TDOC) Is Up 6.7% After Faster BetterHelp Insurance Shift Tightens 2026 Outlook

Teladoc Health's stock rose 6.7% following the acceleration of BetterHelp's nationwide insurance rollout, prompted by higher-than-expected insured demand. This shift, however, reduced the overall BetterHelp revenue outlook due to provider capacity constraints and a quicker move away from cash-pay users. The company's updated guidance …

Noticias de acciones de Teladoc Health Inc (TDOC)

Teladoc Health, Inc. (TDOC) Stock Analysis: Exploring a 16% Upside Potential Amidst Revenue Challenges

Teladoc Health (TDOC) is a leading virtual healthcare provider facing financial challenges despite its innovative role in the sector. The company has a market capitalization of $1.21 billion, with recent revenue decline and negative EPS, yet it maintains a healthy free cash flow. Analysts …

Teladoc Health Inc (TDOC) Stock News Today

This article provides the current stock information for Teladoc Health Inc (TDOC), including its trading price, daily change, market capitalization, and a note that more news will be available soon. It highlights that the stock closed at 7.130 USD, up 6.74%, with a market …

Teladoc Health (TDOC) Securities Investigation Notice - Levi & Korsinsky

Levi & Korsinsky has announced a securities investigation into Teladoc Health (TDOC) after its shares dropped over 28%. This plunge followed Teladoc's report of Q2 2026 revenue below consensus and a cut in its full-year 2026 revenue guidance. The investigation focuses on potential materially …

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

Pomerantz LLP is investigating potential claims on behalf of investors of Teladoc Health, Inc. (NYSE: TDOC) concerning alleged securities fraud or unlawful business practices. This investigation follows Teladoc's updated 2026 revenue guidance, which was significantly lowered due to "uncertainties inherent in cash pay and …

Bronstein, Gewirtz & Grossman, LLC Encourages Teladoc Health, Inc. (TDOC) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating Teladoc Health, Inc. (TDOC) on behalf of investors following a significant drop in its stock price. This drop occurred after Teladoc reported lower-than-expected Q2 2026 revenue and subsequently reduced its full-year 2026 revenue guidance. The firm cites …

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

The Law Offices of Frank R. Cruz has initiated a securities fraud investigation into Teladoc Health Inc. (TDOC) following a significant drop in its stock price. This investigation comes after Teladoc reduced its full-year revenue guidance and reported a more drastic reduction in BetterHelp's …

Dimensional Fund Advisors LP Decreases Stake in Teladoc Health, Inc. $TDOC

Dimensional Fund Advisors LP significantly reduced its stake in Teladoc Health, Inc. by 16% in the first quarter, selling 1.2 million shares but still retaining over 6.3 million shares valued at approximately $34.3 million. Despite beating EPS estimates, Teladoc's revenue declined year-over-year and missed …

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Teladoc Health, Inc. (TDOC) And Encourages Investors to Reach Out

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Teladoc Health, Inc. (TDOC) following the company's Q2 2026 financial results, which reported lower-than-expected revenue and a reduced full-year guidance. The investigation focuses on potential claims for investors who purchased Teladoc Health securities, especially …

Teladoc Health (NYSE: TDOC) director Mark Anquillare submits initial Form 3

Teladoc Health Inc. (NYSE: TDOC) director Mark V. Anquillare has filed an initial Form 3, indicating his beneficial ownership of securities as a director. The filing reports no equity transactions and includes a reference to a Power of Attorney. This Form 3 establishes Anquillare's …

Teladoc Shares Plunged More Than 28% After Earnings. How to Play TDOC Here.

Teladoc Health | 4: Statement of changes in beneficial ownership of securities-Director Anquillare Mark V

This article reports a change in the beneficial ownership of securities for Mark V. Anquillare, a Director at Teladoc Health. The filing is a Statement of Changes in Beneficial Ownership, also known as a Form 4. This indicates that there has been a transaction …

Teladoc Health

This article provides an overview of Teladoc Health (TDOC), a company specializing in telehealthcare services. It details the company's profile, including its founding, headquarters, CEO, and employee count, alongside key financial statistics, stock price performance, and analyst consensus recommendations.

Director Mark V. Anquillare gets 37,425 RSUs at Teladoc Health (TDOC)

Teladoc Health director Mark V. Anquillare was granted 37,425 Restricted Stock Units (RSUs) on August 3, 2026. These RSUs, which represent a contingent right to one share of common stock each, will vest in a staggered manner: one-third on the first anniversary of the …

Teladoc Health (TDOC) On Weaker Earnings And Guidance The Fair Value Debate Returns

Teladoc Health (TDOC) is facing renewed scrutiny after reporting weaker Q2 revenue, a wider net loss, and reduced full-year guidance, leading to a significant stock pullback. Despite a narrative suggesting the stock is 55.5% undervalued with a fair value of $15.00 due to its …

Teladoc Health, Inc. Announces Appointment of Mark V. Anquillare to its Board of Directors and on the Board?s Audit & Compensation Committees, Effective August 3, 2026

Teladoc Health, Inc. has announced the appointment of Mark V. Anquillare to its board of directors, effective August 3, 2026. Mr. Anquillare, former president and COO of Verisk Analytics, brings over 30 years of financial and executive leadership experience. He will serve on the …

The 5 Most Interesting Analyst Questions From Teladoc’s Q2 Earnings Call

Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors

Teladoc Health (NYSE: TDOC) has announced the appointment of financial executive Mark V. Anquillare to its board of directors. Mr. Anquillare, former president and chief operating officer of Verisk Analytics, will serve on the board’s Audit & Compensation committees, bringing over 30 years of …

Teladoc Health | 8-K: Current report

This document is an 8-K current report filed by Teladoc Health. The content of the report itself is not provided in the input, only the document type.

TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Health

SueWallSt is investigating potential securities law violations by Teladoc Health (TDOC) after the company cut its full-year 2026 revenue guidance, leading to a nearly 30% drop in stock value. The investigation focuses on whether Teladoc made false or misleading statements about its revenue outlook. …

Are Investors Undervaluing Teladoc Health (TDOC) Right Now?

The article analyzes why Teladoc Health (TDOC) might be undervalued, highlighting its Zacks Rank #2 (Buy) and an "A" grade for Value. It uses metrics like P/B, P/S, and P/CF ratios to demonstrate that TDOC's valuation is attractive compared to its industry averages. The …

Teladoc Health: Insurance Demand Outpaces Provider Capacity As BetterHelp Revenue Falls 12%

Teladoc Health's BetterHelp division experienced a significant shift towards insurance-covered therapy, leading to a 12% revenue decline as increased demand outpaced provider capacity and could not offset a sharp drop in cash-pay customers. While insurance-covered services saw over a tenfold revenue increase, the transition …

Teladoc Health (TDOC) Is Down 23.5% After Weak Q2 And Lower 2026 Guidance Has The Bull Case Changed?

Teladoc Health (TDOC) reported a challenging Q2 2026 with declining sales, a wider net loss, and lowered full-year 2026 guidance, primarily due to struggles in its BetterHelp mental health unit as users shift to insurance-covered care. This performance pressures the company's investment narrative, which …

Teladoc Health Number of Employees 2026 | Employee Count & Headcount Data

Teladoc Health (TDOC) had 5,704 employees worldwide as of March 2026, marking a 1.7% decline from 2023 but a recovery from a low in 2025. The company is actively hiring with 611 job postings in 2026, and its workforce is primarily concentrated in the …

Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC)

Levi & Korsinsky, LLP has announced an investigation into Teladoc Health (TDOC) after the company's stock dropped over 28% following a disappointing Q2 2026 earnings report and reduced full-year revenue guidance. The investigation focuses on whether Teladoc made false or misleading statements regarding its …

Teladoc Health (TDOC) Could Be 56% Undervalued As Weak Results Reset Expectations

Teladoc Health (TDOC) shares have seen a significant drop after reporting weaker-than-expected Q2 2026 results and revised guidance. Despite recent poor performance, one valuation narrative suggests TDOC could be 56% undervalued with a fair value of $15.00, driven by potential success in its BetterHelp …

Teladoc Health (TDOC) Stock Price Cracks As BetterHelp Reset Deepens

Teladoc Health's stock price dropped over 28% after its Q2 2026 earnings report, largely due to a "reset" in its BetterHelp segment. While Integrated Care showed some positive signs, BetterHelp experienced an 11.6% revenue decline and near break-even EBITDA as it transitions from cash …

Teladoc lowers revenue outlook amid BetterHelp demand headwinds

Teladoc Health has lowered its full-year revenue outlook by 5% due to significant challenges at its mental health unit, BetterHelp. The segment experienced unexpectedly high consumer demand for its insurance offering, which it struggled to meet, causing a faster-than-anticipated decline in its cash-pay business. …

Teladoc Health (TDOC) Stock Looks Cheap Even As The Market Stays Cautious

Teladoc Health (TDOC) stock appears undervalued despite a significant 93.9% decline over the past five years. Both a Discounted Cash Flow (DCF) model and Price/Sales (P/S) ratio analysis suggest the stock is cheap compared to its intrinsic value and industry peers. The company's new …

Teladoc Health trims 2026 revenue forecast amid challenges with BetterHelp insurance shift

Teladoc Health has lowered its 2026 revenue forecast due to unexpected pressure on its BetterHelp virtual behavioral health unit. The company is transitioning BetterHelp from a cash-pay to an insurance-covered model, but consumer demand for insurance-based services is outpacing clinical capacity, leading to a …